自己免疫疾患診断の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測

◆英語タイトル:Autoimmune Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
◆商品コード:MOR21MR098
◆発行会社(リサーチ会社):Mordor Intelligence
◆発行日:2021年2月
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD4,250 ⇒換算¥488,750見積依頼/購入/質問フォーム
Team User(5名利用)USD4,750 ⇒換算¥546,250見積依頼/購入/質問フォーム
Corporate License(法人利用)USD7,500 ⇒換算¥862,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMordor Intelligence社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Mordor Intelligence社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、世界の自己免疫疾患診断市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、疾患別(全身性自己免疫疾患、限局性自己免疫疾患)分析、診断別(抗核抗体検査、自己抗体検査、全血球計算(CBC)、C反応性タンパク質(CRP)、尿検査、その他)分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の自己免疫疾患診断市場規模:疾患別(全身性自己免疫疾患、限局性自己免疫疾患)
・世界の自己免疫疾患診断市場規模:診断別(抗核抗体検査、自己抗体検査、全血球計算(CBC)、C反応性タンパク質(CRP)、尿検査、その他)
・世界の自己免疫疾患診断市場規模:地域別
・競争状況
・市場機会/将来の見通し
【レポートの概要】

The autoimmune disease diagnostics market is expected to register a CAGR of nearly 8.3% during the forecast period. The rising awareness about autoimmune diseases through programs of research, education, support, and advocacy is a key factor boosting the usage rates of autoimmune disease diagnostics, globally. The United States has the highest incidence of autoimmune diseases, wherein about 50 million patients suffer from autoimmune diseases. According to Arthritis Foundation, in 2017 about 54.4 million adults in the United States suffer from diagnosed arthritis. Furthermore, according to the 2017 report of the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number may rise to 629 million, globally.

Government organizations and NGOs aims to increase awareness about the socioeconomic impact of autoimmunity through fostering and facilitating collaboration in the areas of education, public awareness, research, and patient services in an effective, ethical, and efficient manner. The other factors, such as improved laboratory automation, partnerships with physicians and clinical laboratories, and technological advancements, are driving the autoimmune disease diagnostics market. However, the slow turnaround time of the diagnosis and high frequency of false results are hindering the growth of the autoimmune disease diagnostics market.

Key Market Trends

Rheumatoid Arthritis Segment is Expected to Hold a Major Market Share in the Autoimmune Disease Diagnostics Market

Rheumatoid arthritis (RA) is an autoimmune disease that mainly attacks the synovial tissues within the joints. The disease predominantly affects elderly patients. The aging population coupled with technological advancements in immunofluorescence and proteomics technologies will further enhance the rheumatoid arthritis diagnosis influencing the segment growth.

The rising prevalence of diseases such as rheumatoid arthritis, Hashimoto’s thyroiditis, and the presence of favorable government regulations will render a significant impact on the autoimmune disease diagnostics market growth. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune-related disorders. Moreover, the numbers are expected to escalate over the forecast period. The demand for better and precise diagnostic methods, along with the increasing prevalence, is expected to increase over the forecast period.

Asia-Pacific is the Fastest Growing Region in the Autoimmune Disease Diagnostics Market

Asia-Pacific is anticipated to exhibit extensive market growth over the forecast period, owing to the presence of rising disposable income and increasing patient pool in emerging countries. Furthermore, growing awareness regarding the benefits of early and accurate diagnosis of autoimmune diseases to seek right treatment, rising development of healthcare infrastructure, and growing healthcare expenditure are likely to boost the growth of the autoimmune disease diagnostics market in the Asia-Pacific region.

Growth strategies adopted by the local and international players in the Asia-Pacific region is also propelling the growth of the autoimmune disease diagnostics market. In 2017, ImmunArray, a privately-held molecular device diagnostic company, and Kindstar Global Co. Ltd, a speciality clinical testing company based in Wuhan, forged a partnership to undertake joint clinical testing for lupus, due to the growing prevalence of the disease in China.

Competitive Landscape

The Autoimmune Disease Diagnostics Market is fragmented competitive. The market comprises of major market players, and these players are focusing on R&D activities and significant growth strategies. Recently, a few diagnostic companies entered into strategic partnerships with hospitals. This trend is expected to continue over the next few years, in order to meet the high volume of patient needs, across different regions.

In July 2017, AARDA, in partnership with the Relapsing Polychondritis Awareness & Support Foundation (RPASF), hosted the first Bowling Green Autoimmune Walk and Warriors 5K Fun Run to raise awareness and funding for innovative research. In May 2017, Thermo Fisher Scientific acquired Patheon.

In June 2017, Bio-Rad signed an agreement with VISIA imaging for fully-automated IFA Slide Processing and Reading System. Thus, the market has been witnessing technological developments on a large scale for the past couple of years.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

【レポートの目次】

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Autoimmune Diseases and Rising Public Awareness​
4.2.2 Technological Advancements and Improved Laboratory Automation​
4.3 Market Restraints
4.3.1 Slow Turnaround Time of Results and Need for Multiple Diagnostic Tests
4.3.2 High Cost of the Diagnostics
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Disease Type
5.1.1 Systemic Autoimmune Disease
5.1.1.1 Rheumatoid Arthritis
5.1.1.2 Psoriasis
5.1.1.3 Systemic Lupus Erythematosus (SLE)
5.1.1.4 Multiple Sclerosis
5.1.1.5 Other Systemic Autoimmune Diseases
5.1.2 Localized Autoimmune Disease
5.1.2.1 Inflammatory Bowel Disease
5.1.2.2 Type 1 Diabetes
5.1.2.3 Thyroid
5.1.2.4 Other Localized Autoimmune Diseases
5.2 By Diagnosis
5.2.1 Antinuclear Antibody Tests​
5.2.2 Autoantibody Tests​
5.2.3 Complete Blood Count (CBC)​
5.2.4 C-reactive Protein (CRP)​
5.2.5 Urinalysis​
5.2.6 Others tests
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Biomerieux
6.1.3 Bio-rad Laboratories
6.1.4 Euroimmun AG
6.1.5 F. Hoffmann-la Roche
6.1.6 Inova Diagnostics Inc.
6.1.7 Myriad Genetics
6.1.8 Siemens Healthineers Inc.
6.1.9 Thermo Fisher Scientific
6.1.10 Trinity Biotech

7 MARKET OPPORTUNITIES AND FUTURE TRENDS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[自己免疫疾患診断の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆